Clinical and Immunological Evaluation of HA in Treatment of Periodontitis
- Disease/Condition
- Periodontitis
- Drug/Device/Intervention
- Hyaluronic acid
- Study type
- Interventional
- Intervention type
- drug
- Primary sponsor
- Sana'a University
- Location
- Sana'a, Yemen
- Phase
- N/A
- Start date
- Apr 01, 2024
- End date
- Dec 12, 2024
- Enrollment
- 24 participants
Changes in Plaque Index,Changes in Gingival Index,Changes in Papillary Bleeding Index.,Periodontal Probing Depth,Clinical attachment loss,Changes in IGF-1
To evaluate the immunological effectiveness of Hyaluronic acid as adjunction treatment to
 scaling and root planning and scaling and root planning alone.
 
 Comparison between clinical measurement before and after treatment. Evaluate the level of
 IGF-1 in treated site as immunological marker if periodontal regeneration.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06324474
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06324474 through Pure Global AI's free database. This phase not specified trial is sponsored by Sana'a University and is currently Not yet recruiting. The study focuses on Periodontitis. Target enrollment is 24 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.